Meropenem
Carbapenem- Drug Class
- Carbapenem
- Mechanism of Action (MOA)
- β-lactam: inhibits PBPs; the broadest β-lactam spectrum.
- Clinical Notes
- Reserved for MDR/ESBL gram-negatives and serious polymicrobial infection. Seizure risk (less than imipenem); no MRSA/atypical coverage.
- Source
- FDA label
Sources
Reviewed June 2026- FDA label — FDA / DailyMed
Checked against the guideline or standard reference the exam keys to. If it has moved, use Report an error below.
Same family
Got a pharmacology lecture that covers Meropenem? Turn it into flashcards and board-style questions, free. Drop it on the home page
All pharmacology